Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Neuroendocrine Responses to High-Intensity Reactive Exercises: Effects on Catecholamine and Hormonal Profiles in Elite U-19 Volleyball Players

14 listopada 2026 zaktualizowane przez: Youssef Zekailiche, Mohamed Lamine Debaghine Setif 2 University

Acute Catecholamine and Glucocorticoid Responses to Reactive Speed, Agility, and Quickness Exercise in Elite U-19 Volleyball Players: A Randomized Controlled Study

The goal of this explored study intends to investigate how different types of speed, agility, and quickness (SAQ) exercises effect the body's immediate hormonal and physiological reactions in young male volleyball players. Physical exercise can alter the release of hormones and other substances involved in the body's response to physical effort and stress. However, it is still ambiguous if activities that necessitate swift reflexes to unforeseen visual stimuli provide distinct outcomes in contrast to conventional exercises that entail premeditated movements. The study will include 36 competitive male volleyball players under 19 years of age from the Algerian Amateur League. Participants will be randomly assigned to one of three groups, with 12 players in each group. The first group will conduct a 10-minute reactive training session using BlazePod, an interactive lighting system that requires participants to respond swiftly to visual inputs. The second cohort will engage in a 20-minute session with the identical approach, featuring increased workout repetitions and varied rest intervals. The third group will do 10 minutes of standard volleyball-related workouts without interactive visual indications. All participants will complete one supervised workout session. Blood samples will be collected roughly five minutes before exercise and within two minutes after exercise to assess five substances: epinephrine (adrenaline), norepinephrine (noradrenaline), dopamine, cortisol, and cortisone. These chemicals are involved in the body's responses to physical exertion and stress. Heart rate will also be recorded, and participants will report how physically challenging they found the exercises using a simple grading scale. Investigators will analyse data collected prior to and following physical activity and assess if the variations differ among the three cohorts. The study intends to better understanding of how exercise duration, physical demands, and responsiveness to visual signals may influence acute hormonal responses in young volleyball players. The results could assist researchers and sports experts in comprehending the physical requirements of reactionary exercise and inform subsequent studies on athletic training. The study is not meant to assess if these activities increase long-term sports performance. No results are currently available, and it is not yet known whether one workout strategy will create distinct hormonal reactions from another.

Przegląd badań

Status

Aktywny, nie rekrutujący

Warunki

Interwencja / Leczenie

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

36

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

      • Sétif, Algieria
        • Mohamed Lamine Debaghine Setif 2 University.

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

17 lat do 18 lat (Dziecko, Dorosły)

Akceptuje zdrowych ochotników

Tak

Płeć kwalifikująca się do nauki

Męski

Opis

Inclusion Criteria:

  • Male volleyball players within the U-19 age category.
  • Active participation in organized competitive volleyball.
  • Sufficient physical capacity to complete the prescribed high-intensity exercise protocols.
  • Absence of musculoskeletal injury or medical conditions that could compromise safe participation.
  • Willingness to complete the experimental procedures, including pre- and post-exercise venous blood sampling.

Exclusion Criteria:

  • Current musculoskeletal injury or persistent pain affecting physical performance.
  • Diagnosed cardiovascular, metabolic, endocrine, or neurological disorders that could influence exercise tolerance or biochemical responses.
  • Use of medications or substances known to affect sympathetic nervous system activity, catecholamine secretion, or glucocorticoid regulation.
  • Inability to complete the assigned exercise protocol or blood sampling procedures.
  • Withdrawal of consent at any stage of the investigation.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Podstawowa nauka
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: High-Intensity Exercise Group

12 individuals are participating in high-intensity physical training as part of supervised sessions. Heart rate and perceived exertion levels will be monitored, and blood samples will be collected before and after the program.

12 participants will undergo a single high-intensity exercise session under the supervision of specialists. The session will include a warm-up phase, followed by continuous moderate-intensity exercise, and will conclude with a cool-down phase. Exercise intensity will be monitored by measuring heart rate and assessing the perceived level of exertion. Additionally, blood samples will be collected before and after the session to evaluate hormonal responses.

Eksperymentalny: Moderate-Intensity Exercise Group

12 individuals will participate in moderate-intensity physical training as part of supervised sessions. Heart rate and perceived exertion levels will be monitored, and blood samples will be collected before and after the program.

12 participants will undergo a single moderate-intensity exercise session under the supervision of specialists. The session will include a warm-up phase, followed by continuous moderate-intensity exercise, and will conclude with a cool-down phase. Exercise intensity will be monitored by measuring heart rate and assessing the perceived level of exertion. Additionally, blood samples will be collected before and after the session to evaluate hormonal responses.

Brak interwencji: Control Group

12 participants will not undergo any physical intervention; instead, they will continue with their usual daily activities. Blood samples will be collected at the same time points established for the exercise groups.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Change in Plasma Epinephrine Level
Ramy czasowe: Before and immediately after the single exercise session

Plasma epinephrine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Plasma Norepinephrine Level
Ramy czasowe: Before and immediately after the single exercise session

Plasma norepinephrine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Plasma Dopamine Level
Ramy czasowe: Before and immediately after the single exercise session

Plasma dopamine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Serum Cortisol Level
Ramy czasowe: Before and immediately after the single exercise session

Serum cortisol concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Serum Cortisone Level
Ramy czasowe: Before and immediately after the single exercise session

Serum cortisone concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Peak Heart Rate During Exercise
Ramy czasowe: During the exercise session

Peak heart rate (HRpeak) will be measured continuously during each exercise session using a heart rate monitor. HRpeak will then be compared across the three groups: the high-intensity exercise group, the moderate-intensity exercise group, and the control group.

During the exercise session
Rating of Perceived Exertion
Ramy czasowe: During and immediately after the single exercise session

The Rate of Perceived Exertion (RPE) will be assessed using the Borg scale during and immediately after each exercise session. RPE values will then be compared across the three groups: the high-intensity exercise group, the moderate-intensity exercise group, and the control group.

During and immediately after the single exercise session

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Śledczy

  • Główny śledczy: YOUSSEF ZEKAILICHE, Ph.D., Mohamed Lamine Debaghine Setif 2 University Laboratory Sciences of Physical Activities, Sports, and Public Health, Algeria.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

5 października 2026

Zakończenie podstawowe (Rzeczywisty)

15 października 2026

Ukończenie studiów (Szacowany)

5 grudnia 2026

Daty rejestracji na studia

Pierwszy przesłany

14 listopada 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

14 listopada 2026

Pierwszy wysłany (Rzeczywisty)

19 listopada 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

19 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

14 listopada 2026

Ostatnia weryfikacja

1 listopada 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • SETIF2-01-2026

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Opis planu IPD

Individual participant data will not be shared to protect participant confidentiality and privacy, as this is a small single-site. Only aggregated and anonymized results will be reported.

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .